Curevo Vaccine

Acquired

Creating Better Vaccines

Bothell, United States · Founded 2017 · $196.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$196.0M
Last Round
$110.0M Series BMar 2025
Rounds
3
Acquisition Date
May 2026

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Curevo Vaccine is a clinical-stage biotechnology company founded in 2017 and headquartered in Bothell, Washington. It develops next-generation non-mRNA adjuvanted subunit vaccines targeting unmet medical needs, with its lead program amezosvatein (CRV-101) advancing through Phase 2 clinical trials for shingles and chickenpox with superior tolerability versus Shingrix.

Summary

Curevo Vaccine is a Biotech company based in Bothell, United States, founded in 2017. It has raised $196.0M in total across 3 rounds, most recently a $110.0M Series B round in Mar 2025. Investors include Janus Henderson Investors, Eli Lilly and Medicxi.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionMay 2026

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Curevo Vaccine on Indexed.vc
<a href="https://indexed.vc/companies/curevo-vaccine"><img src="https://indexed.vc/api/badge/company/curevo-vaccine" alt="Curevo Vaccine on Indexed.vc" width="260" height="76" /></a>